NYSE:TMO - Thermo Fisher Scientific Stock Price, Price Target & More

$217.49 +1.60 (+0.74 %)
(As of 04/23/2018 10:54 AM ET)
Previous Close$215.89
Today's Range$216.51 - $218.05
52-Week Range$156.03 - $226.44
Volume129,870 shs
Average Volume1.46 million shs
Market Capitalization$86.74 billion
P/E Ratio22.96
Dividend Yield0.31%
Beta1.14

About Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific logoThermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolNYSE:TMO
CUSIP88355610
Phone781-622-1000

Debt

Debt-to-Equity Ratio0.74%
Current Ratio1.34%
Quick Ratio0.92%

Price-To-Earnings

Trailing P/E Ratio22.96
Forward P/E Ratio20.06
P/E Growth1.59

Sales & Book Value

Annual Sales$20.92 billion
Price / Sales4.18
Cash Flow$14.5966 per share
Price / Cash14.90
Book Value$63.38 per share
Price / Book3.43

Profitability

EPS (Most Recent Fiscal Year)$9.49
Net Income$2.23 billion
Net Margins10.64%
Return on Equity16.01%
Return on Assets7.35%

Miscellaneous

Employees70,000
Outstanding Shares401,780,000

How to Become a New Pot Stock Millionaire

Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific declared a quarterly dividend on Wednesday, January 31st. Shareholders of record on Thursday, March 15th will be given a dividend of $0.17 per share on Monday, April 16th. This represents a $0.68 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date of this dividend is Wednesday, March 14th. This is a boost from Thermo Fisher Scientific's previous quarterly dividend of $0.15. View Thermo Fisher Scientific's Dividend History.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific (NYSE:TMO) released its quarterly earnings data on Wednesday, January, 31st. The medical research company reported $2.79 earnings per share for the quarter, beating analysts' consensus estimates of $2.66 by $0.13. The medical research company had revenue of $6.05 billion for the quarter, compared to analysts' expectations of $5.72 billion. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. Thermo Fisher Scientific's quarterly revenue was up 22.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.41 EPS. View Thermo Fisher Scientific's Earnings History.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, April, 25th 2018. View Earnings Estimates for Thermo Fisher Scientific.

What guidance has Thermo Fisher Scientific issued on next quarter's earnings?

Thermo Fisher Scientific issued an update on its FY18 earnings guidance on Wednesday, January, 31st. The company provided EPS guidance of $10.68-10.88 for the period, compared to the Thomson Reuters consensus EPS estimate of $10.63. The company issued revenue guidance of $23.42-23.72 billion, compared to the consensus revenue estimate of $22.99 billion.

What price target have analysts set for TMO?

15 analysts have issued 12-month target prices for Thermo Fisher Scientific's shares. Their forecasts range from $194.00 to $250.00. On average, they expect Thermo Fisher Scientific's stock price to reach $220.0769 in the next twelve months. View Analyst Ratings for Thermo Fisher Scientific.

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:
  • Mr. Marc N. Casper, CEO, Pres & Director (Age 50)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 51)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 55)
  • Mr. Peter E. Hornstra, VP & Chief Accounting Officer (Age 58)
  • Dr. Alan B. Sachs, Chief Scientific Officer

Has Thermo Fisher Scientific been receiving favorable news coverage?

Media headlines about TMO stock have been trending somewhat positive on Monday, according to Accern Sentiment. Accern scores the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Thermo Fisher Scientific earned a news sentiment score of 0.03 on Accern's scale. They also assigned media headlines about the medical research company an impact score of 45.50 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $217.95.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $86.74 billion and generates $20.92 billion in revenue each year. The medical research company earns $2.23 billion in net income (profit) each year or $9.49 on an earnings per share basis. Thermo Fisher Scientific employs 70,000 workers across the globe.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]


MarketBeat Community Rating for Thermo Fisher Scientific (TMO)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  535 (Vote Outperform)
Underperform Votes:  242 (Vote Underperform)
Total Votes:  777
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe TMO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Thermo Fisher Scientific (NYSE:TMO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
15 Wall Street analysts have issued ratings and price targets for Thermo Fisher Scientific in the last 12 months. Their average twelve-month price target is $220.0769, suggesting that the stock has a possible upside of 1.19%. The high price target for TMO is $250.00 and the low price target for TMO is $194.00. There are currently 1 hold rating and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.932.932.932.93
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $220.0769$220.9231$212.00$203.00
Price Target Upside: 1.19% upside0.07% downside6.54% upside5.07% upside

Thermo Fisher Scientific (NYSE:TMO) Consensus Price Target History

Price Target History for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific (NYSE:TMO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/11/2018Morgan StanleyLower Price TargetOverweight -> Overweight$228.00 -> $216.00LowView Rating Details
2/1/2018Bank of AmericaBoost Price TargetBuy -> Buy$235.00 -> $250.00LowView Rating Details
2/1/2018BarclaysBoost Price TargetOverweight -> Overweight$225.00 -> $245.00LowView Rating Details
2/1/2018Leerink SwannReiterated RatingOutperform$200.00 -> $239.00LowView Rating Details
1/5/2018BTIG ResearchInitiated CoverageBuy -> Buy$230.00MediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform$220.00MediumView Rating Details
10/26/2017Deutsche BankSet Price TargetBuy$216.00 -> $226.00N/AView Rating Details
9/28/2017Jefferies GroupReiterated RatingHold$195.00LowView Rating Details
9/26/2017Goldman SachsInitiated CoverageBuy$225.00LowView Rating Details
9/10/2017CowenReiterated RatingOutperform$200.00 -> $220.00LowView Rating Details
8/22/2017ArgusReiterated RatingBuyMediumView Rating Details
7/20/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
7/13/2017Wells FargoReiterated RatingOutperform$195.00 -> $200.00LowView Rating Details
7/10/2017CitigroupReiterated RatingBuy$182.00 -> $201.00LowView Rating Details
5/18/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$194.00LowView Rating Details
9/27/2016UBSReiterated RatingBuy$176.00N/AView Rating Details
9/22/2016JPMorgan ChaseInitiated CoverageOverweight$180.00N/AView Rating Details
7/28/2016MizuhoSet Price TargetBuy$170.00 -> $175.00N/AView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Thermo Fisher Scientific (NYSE:TMO) Earnings History and Estimates Chart

Earnings by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific (NYSE:TMO) Earnings Estimates

2018 EPS Consensus Estimate: $10.79
2019 EPS Consensus Estimate: $11.80
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$2.40$2.42$2.41
Q2 20182$2.62$2.69$2.66
Q3 20182$2.61$2.63$2.62
Q4 20182$3.10$3.11$3.11
Q1 20191$2.65$2.65$2.65
Q2 20191$2.88$2.88$2.88
Q3 20191$2.89$2.89$2.89
Q4 20191$3.38$3.38$3.38

Thermo Fisher Scientific (NYSE TMO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018$2.40N/AView Earnings Details
1/31/2018Q4 2017$2.66$2.79$5.7171 billion$6.0470 billionViewListenView Earnings Details
10/25/2017Q3 2017$2.24$2.31$5.0285 billion$5.1162 billionViewN/AView Earnings Details
7/26/2017Q2 2017$2.27$2.30$4.9225 billion$4.9990 billionViewN/AView Earnings Details
4/26/2017Q1 2017$2.0230$2.08$4.6774 billion$4.7650 billionViewN/AView Earnings Details
1/31/2017Q416$2.38$2.41$4.98 billion$4.95 billionViewN/AView Earnings Details
10/27/2016Q316$1.97$2.03$4.39 billion$4.49 billionViewListenView Earnings Details
7/28/2016Q216$2.01$2.03$4.50 billion$4.54 billionViewListenView Earnings Details
4/28/2016Q116$1.74$1.80$4.11 billion$4.29 billionViewListenView Earnings Details
1/28/2016Q415$2.11$2.12$4.55 billion$4.65 billionViewListenView Earnings Details
10/21/2015Q315$1.79$1.80$4.10 billion$4.12 billionViewListenView Earnings Details
7/22/2015Q215$1.78$1.84$4.17 billion$4.27 billionViewListenView Earnings Details
4/22/2015Q115$1.61$1.63$4.01 billion$3.92 billionViewN/AView Earnings Details
1/29/2015Q414$1.94$1.99$4.39 billion$4.49 billionViewN/AView Earnings Details
10/22/2014Q314$1.69$1.71$4.21 billion$4.17 billionViewListenView Earnings Details
7/23/2014Q214$1.62$1.72$4.25 billion$4.32 billionViewN/AView Earnings Details
4/23/2014Q114$1.40$1.53$3.74 billion$3.90 billionViewN/AView Earnings Details
1/31/2014Q413$1.38$1.43$3.31 billion$3.47 billionViewN/AView Earnings Details
10/23/2013Q313$1.28$1.30$3.18 billion$3.19 billionViewListenView Earnings Details
7/24/2013Q2 2013$1.30$1.32$3.22 billion$3.24 billionViewListenView Earnings Details
4/24/2013Q1 2013$1.29$1.37$3.17 billion$3.19 billionViewListenView Earnings Details
1/31/2013Q4 2012$1.28$1.36$3.13 billion$3.26 billionViewListenView Earnings Details
10/24/2012$1.16$1.19ViewN/AView Earnings Details
7/25/2012$1.16$1.22ViewN/AView Earnings Details
4/25/2012$1.11$1.17ViewN/AView Earnings Details
2/1/2012$1.16$1.18ViewN/AView Earnings Details
10/26/2011$1.07$1.07ViewN/AView Earnings Details
7/27/2011$0.98$0.99ViewN/AView Earnings Details
4/27/2011$0.88$0.92ViewN/AView Earnings Details
2/2/2011$0.95$1.00ViewN/AView Earnings Details
10/27/2010Q3 2010$0.83$0.90ViewN/AView Earnings Details
7/27/2010Q2 2010$0.84$0.84ViewN/AView Earnings Details
4/28/2010Q1 2010$0.75$0.84ViewN/AView Earnings Details
2/3/2010Q4 2009$0.88$0.91ViewN/AView Earnings Details
10/22/2009Q3 2009$0.76$0.78ViewN/AView Earnings Details
7/23/2009Q2 2009$0.67$0.74ViewN/AView Earnings Details
4/23/2009Q1 2009$0.70$0.62ViewN/AView Earnings Details
2/4/2009Q4 2008$0.83$0.88ViewN/AView Earnings Details
10/23/2008Q3 2008$0.76$0.76ViewN/AView Earnings Details
7/24/2008Q2 2008$0.77$0.79ViewN/AView Earnings Details
4/24/2008Q1 2008$0.72$0.74ViewN/AView Earnings Details
2/6/2008Q4 2007$0.69$0.76ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Thermo Fisher Scientific (NYSE:TMO) Dividend Information

Thermo Fisher Scientific pays an annual dividend of $0.68 per share, with a dividend yield of 0.31%. TMO's most recent quarterly dividend payment was Monday, April 16. Thermo Fisher Scientific pays out 7.17% of its earnings out as a dividend.
Most Recent Dividend:4/16/2018
Annual Dividend:$0.68
Dividend Yield:0.31%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:7.17% (Trailing 12 Months of Earnings)
6.27% (Based on This Year's Estimates)
5.63% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific (NYSE:TMO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/31/2018quarterly$0.170.33%3/14/20183/15/20184/16/2018
11/9/2017quarterly$0.150.32%12/14/201712/15/20171/15/2018
7/12/2017quarterly$0.150.33%9/14/20179/15/201710/16/2017
5/18/2017quarterly$0.150.35%6/13/20176/15/20177/17/2017
2/28/2017quarterly$0.150.38%3/13/20173/15/20174/17/2017
11/10/2016quarterly$0.150.4%12/13/201612/15/20161/16/2017
7/7/2016quarterly$0.150.39%9/13/20169/15/201610/17/2016
5/18/2016quarterly$0.150.4%6/13/20166/15/20167/15/2016
2/25/2016quarterly$0.150.46%3/11/20163/15/20164/15/2016
11/12/2015quarterly$0.150.45%12/11/201512/15/20151/15/2016
7/10/2015quarterly$0.150.45%9/11/20159/15/201510/15/2015
5/21/2015quarterly$0.150.45%6/11/20156/15/20157/15/2015
2/26/2015quarterly$0.150.46%3/12/20153/16/20154/15/2015
11/7/2014quarterly$0.150.51%12/11/201412/15/20141/15/2015
7/10/2014quarterly$0.150.51%9/11/20149/15/201410/15/2014
5/21/2014quarterly$0.156/12/20146/16/20147/15/2014
2/27/2014quarterly$0.150.48%3/13/20143/17/20144/15/2014
11/8/2013quarterly$0.150.61%12/12/201312/16/20131/15/2014
7/12/2013quarterly$0.150.68%9/12/20139/16/201310/15/2013
5/23/2013quarterly$0.150.69%6/13/20136/17/20137/15/2013
2/27/2013quarterly$0.150.81%3/13/20133/15/20134/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Thermo Fisher Scientific (NYSE TMO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.49%
Institutional Ownership Percentage: 87.19%
Insider Trading History for Thermo Fisher Scientific (NYSE:TMO)
Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific (NYSE TMO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2018Marc N CasperCEOSell40,000$210.16$8,406,400.00334,622View SEC Filing  
3/5/2018Stephen WilliamsonCFOSell2,500$204.60$511,500.00View SEC Filing  
2/23/2018William G ParrettDirectorSell1,000$211.43$211,430.0011,660View SEC Filing  
2/15/2018William G ParrettDirectorSell1,000$209.80$209,800.00View SEC Filing  
2/7/2018Stephen WilliamsonCFOSell5,000$209.26$1,046,300.0030,741View SEC Filing  
2/5/2018Patrick M DurbinInsiderSell6,000$217.55$1,305,300.00View SEC Filing  
2/2/2018Gregory J HerremaSVPSell33,327$219.70$7,321,941.9060,471View SEC Filing  
12/15/2017Marc N CasperCEOSell50,000$191.74$9,587,000.00302,577View SEC Filing  
11/15/2017Marc N CasperCEOSell50,000$188.39$9,419,500.00252,577View SEC Filing  
9/5/2017Peter E HornstraVPSell3,894$185.18$721,090.9219,751View SEC Filing  
8/30/2017C Martin HarrisDirectorSell360$180.97$65,149.205,312View SEC Filing  
8/30/2017Daniel P ShineInsiderSell2,026$180.97$366,645.2220,682View SEC Filing  
8/28/2017Seth H HoogasianVPSell4,140$177.80$736,092.0025,518View SEC Filing  
8/18/2017Jim P ManziDirectorSell11,318$172.94$1,957,334.9238,757View SEC Filing  
8/17/2017Jim P ManziDirectorSell1,000$175.20$175,200.0038,757View SEC Filing  
8/2/2017Gregory J HerremaSVPSell30,000$176.02$5,280,600.0067,016View SEC Filing  
6/5/2017Stephen WilliamsonCFOSell2,500$176.26$440,650.0037,790View SEC Filing  
6/1/2017Marc N CasperCEOSell20,000$172.79$3,455,800.00269,279View SEC Filing  
5/24/2017Daniel P ShineInsiderSell4,688$171.88$805,773.4429,200View SEC Filing  
4/27/2017Thomas W LoewaldInsiderSell1,532$168.76$258,540.3241,277View SEC Filing  
3/15/2017Marc N CasperCEOSell20,000$158.60$3,172,000.00289,279View SEC Filing  
3/15/2017Peter M WilverVPSell9,079$160.73$1,459,267.6762,517View SEC Filing  
3/10/2017Peter M WilverVPSell9,987$158.18$1,579,743.6677,233View SEC Filing  
3/8/2017Thomas W LoewaldInsiderSell7,675$157.39$1,207,968.2550,484View SEC Filing  
3/6/2017Seth H HoogasianVPSell3,142$158.71$498,666.8231,104View SEC Filing  
3/6/2017Stephen WilliamsonCFOSell2,500$158.71$396,775.0040,290View SEC Filing  
3/6/2017Thomas W LoewaldSVPSell4,049$158.71$642,616.7942,809View SEC Filing  
9/2/2016Marc N CasperCEOSell28,797$151.01$4,348,634.97307,444View SEC Filing  
9/1/2016Marc N CasperCEOSell30,000$151.17$4,535,100.00308,647View SEC Filing  
8/29/2016Daniel P ShineSVPSell1,699$152.28$258,723.7217,437View SEC Filing  
8/29/2016Seth H HoogasianVPSell2,270$152.28$345,675.6027,384View SEC Filing  
8/29/2016Thomas W LoewaldInsiderSell3,256$152.28$495,823.6835,814View SEC Filing  
8/26/2016Thomas W LoewaldInsiderSell913$151.92$138,702.9639,983View SEC Filing  
8/10/2016Seth H HoogasianVPSell5,023$156.00$783,588.0031,914View SEC Filing  
8/5/2016C Martin HarrisDirectorSell390$157.33$61,358.704,648View SEC Filing  
7/13/2016Thomas W LoewaldSVPSell8,025$155.00$1,243,875.0052,194View SEC Filing  
7/5/2016Marc N CasperCEOSell20,000$147.69$2,953,800.00340,998View SEC Filing  
7/1/2016Marc N CasperCEOSell30,000$148.85$4,465,500.00350,998View SEC Filing  
6/15/2016Daniel P ShineSVPSell6,900$148.31$1,023,339.0028,779View SEC Filing  
6/10/2016Peter M WilverVPSell68,200$152.38$10,392,316.0064,727View SEC Filing  
6/3/2016Jim P ManziDirectorSell1,137$153.00$173,961.0038,733View SEC Filing  
6/2/2016Thomas W LoewaldSVPSell15,000$152.84$2,292,600.0049,169View SEC Filing  
5/16/2016Peter E HornstraCAOSell7,811$150.00$1,171,650.0021,246View SEC Filing  
4/26/2016Daniel P ShineSVPSell6,013$146.00$877,898.0027,892View SEC Filing  
4/5/2016Seth H HoogasianVPSell10,000$141.86$1,418,600.0046,937View SEC Filing  
4/4/2016Patrick M DurbinSVPSell16,250$142.18$2,310,425.0038,548View SEC Filing  
3/21/2016Stephen WilliamsonCFOSell10,708$139.50$1,493,766.0028,016View SEC Filing  
3/14/2016Marc N CasperCEOSell30,000$139.28$4,178,400.00350,998View SEC Filing  
3/10/2016Alan J MalusEVPSell25,925$139.05$3,604,871.2565,136View SEC Filing  
3/9/2016Alan J MalusEVPSell15,446$138.50$2,139,271.0062,732View SEC Filing  
3/3/2016Scott M SperlingDirectorSell5,350$137.90$737,765.0085,790View SEC Filing  
3/3/2016Thomas W LoewaldSVPSell3,625$137.28$497,640.0047,794View SEC Filing  
3/1/2016Seth H HoogasianVPSell2,951$135.00$398,385.0036,937View SEC Filing  
2/1/2016Alan J. MalusEVPSell103,400$130.24$13,466,816.0045,821View SEC Filing  
1/15/2016Daniel P. ShineSVPSell6,000$131.77$790,620.0016,944View SEC Filing  
12/14/2015Thomas W. LoewaldSVPSell13,013$134.18$1,746,084.3431,438View SEC Filing  
12/11/2015William G ParrettDirectorBuy1,000$134.16$134,160.0014,636View SEC Filing  
12/7/2015Alan J. MalusEVPSell82,300$135.49$11,150,827.0045,821View SEC Filing  
11/4/2015Seth H HoogasianVPSell1,692$135.00$228,420.0033,415View SEC Filing  
11/3/2015C Martin HarrisDirectorSell531$134.35$71,339.854,038View SEC Filing  
11/2/2015Jim P. ManziDirectorSell3,050$133.49$407,144.5038,870View SEC Filing  
9/17/2015Marc N CasperCEOSell25,000$130.00$3,250,000.00360,607View SEC Filing  
8/28/2015Alan J MalusEVPSell4,557$127.55$581,245.3545,821View SEC Filing  
7/14/2015Andrew J ThomsonSVPSell5,000$135.23$676,150.00View SEC Filing  
7/14/2015Peter E HornstraCAOSell7,381$136.02$1,003,963.62View SEC Filing  
6/3/2015Tyler JacksDirectorSell15,000$129.95$1,949,250.00View SEC Filing  
6/1/2015Alan J MalusEVPSell40,350$129.54$5,226,939.00View SEC Filing  
5/26/2015Thomas J LynchDirectorSell5,000$131.09$655,450.00View SEC Filing  
5/21/2015Peter M WilverCFOSell28,100$133.00$3,737,300.00View SEC Filing  
4/23/2015Thomas J LynchDirectorSell5,000$130.15$650,750.00View SEC Filing  
4/21/2015Seth H HoogasianVPSell13,256$135.00$1,789,560.00View SEC Filing  
4/13/2015Alan J MalusEVPSell11,032$133.67$1,474,647.44View SEC Filing  
4/13/2015Andrew J ThomsonSVPSell12,425$133.50$1,658,737.50View SEC Filing  
4/1/2015Marc N CasperCEOSell20,000$131.89$2,637,800.00View SEC Filing  
3/30/2015Thomas J LynchDirectorSell5,000$134.40$672,000.00View SEC Filing  
3/30/2015Thomas W LoewaldSVPSell5,307$134.40$713,260.80View SEC Filing  
3/9/2015Alan J MalusEVPSell14,479$128.11$1,854,904.69View SEC Filing  
2/23/2015Edward A PesickaSVPSell28,713$130.93$3,759,393.09View SEC Filing  
2/20/2015Peter M WilverCFOSell50,700$130.12$6,597,084.00View SEC Filing  
2/20/2015Thomas W LoewaldSVPSell15,037$127.94$1,923,833.78View SEC Filing  
2/5/2015Alan J MalusEVPSell50,000$126.83$6,341,500.00View SEC Filing  
12/18/2014Alan J MalusEVPSell11,618$125.20$1,454,573.60View SEC Filing  
11/19/2014Peter E HornstraCAOSell8,363$125.00$1,045,375.00View SEC Filing  
8/27/2014Alan J MalusEVPSell13,115$120.61$1,581,800.15View SEC Filing  
8/27/2014Seth H HoogasianVPSell10,577$120.77$1,277,384.29View SEC Filing  
8/27/2014Thomas W LoewaldSVPSell2,349$120.90$283,994.10View SEC Filing  
7/30/2014Seth H HoogasianVPSell5,103$123.82$631,853.46View SEC Filing  
7/25/2014Thomas W LoewaldSVPSell6,000$125.23$751,380.00View SEC Filing  
4/29/2014Jim ManziDirectorSell3,000$114.85$344,550.0040,997View SEC Filing  
4/28/2014Thomas LoewaldSVPSell8,688$114.49$994,689.1241,307View SEC Filing  
3/24/2014Edward PesickaSVPSell80,044$120.75$9,665,313.00101,030View SEC Filing  
2/26/2014Alan MalusEVPSell7,640$124.11$948,200.40125,710View SEC Filing  
2/14/2014Andrew ThomsonSVPSell16,725$123.14$2,059,516.5046,159View SEC Filing  
2/10/2014Peter HornstraCAOSell9,234$117.72$1,087,026.4819,242View SEC Filing  
2/7/2014Marc CasperCEOSell208,765$115.70$24,154,110.50229,730View SEC Filing  
2/7/2014Peter WilverCFOSell91,897$115.21$10,587,453.37104,305View SEC Filing  
2/6/2014Thomas LoewaldSVPSell22,437$114.24$2,563,202.8840,483View SEC Filing  
2/6/2014William ParrettDirectorSell18,000$114.33$2,057,940.0011,188View SEC Filing  
9/16/2013Alan MalusEVPSell4,000$91.87$367,480.00138,360View SEC Filing  
8/15/2013Alan MalusEVPSell4,000$91.11$364,440.00143,785View SEC Filing  
7/24/2013Edward A PesickaSVPSell80,700$91.00$7,343,700.00View SEC Filing  
6/17/2013Marc N CasperCEOSell43,396$85.58$3,713,829.68View SEC Filing  
6/17/2013Seth H HoogasianVPSell35,431$85.59$3,032,539.29View SEC Filing  
6/10/2013Judy C LewentDirectorSell15,000$85.19$1,277,850.00View SEC Filing  
6/7/2013Edward A PesickaSVPSell167,980$85.28$14,325,334.40View SEC Filing  
5/24/2013C Martin HarrisDirectorSell1,260$87.21$109,884.60View SEC Filing  
5/15/2013Alan J MalusEVPSell4,000$84.43$337,720.00View SEC Filing  
5/14/2013Scott M SperlingDirectorSell8,000$84.65$677,200.00View SEC Filing  
5/7/2013Andrew J ThomsonSVPSell12,700$83.65$1,062,355.00View SEC Filing  
5/7/2013Jim P ManziDirectorSell7,500$82.78$620,850.00View SEC Filing  
11/1/2012Marc N CasperCEOSell125,000$62.49$7,811,250.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Thermo Fisher Scientific (NYSE TMO) News Headlines

Source:
DateHeadline
Thermo Fisher Scientific: A Quality Company Trading At A Quality PriceThermo Fisher Scientific: A Quality Company Trading At A Quality Price
seekingalpha.com - April 23 at 9:42 AM
Thermo Fisher Scientific (TMO) Upgraded by BidaskClub to "Strong-Buy"Thermo Fisher Scientific (TMO) Upgraded by BidaskClub to "Strong-Buy"
www.americanbankingnews.com - April 19 at 12:49 PM
Thermo Fisher Scientific (TMO) Given Consensus Recommendation of "Buy" by AnalystsThermo Fisher Scientific (TMO) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - April 19 at 1:36 AM
Thermo Fisher Scientific (TMO) Set to Announce Earnings on WednesdayThermo Fisher Scientific (TMO) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - April 18 at 2:30 AM
Whats in the Offing for Thermo Fisher (TMO) in Q1 Earnings?What's in the Offing for Thermo Fisher (TMO) in Q1 Earnings?
finance.yahoo.com - April 16 at 4:37 PM
What's in the Offing for Thermo Fisher (TMO) in Q1 Earnings?What's in the Offing for Thermo Fisher (TMO) in Q1 Earnings?
finance.yahoo.com - April 16 at 4:37 PM
Thermo Fisher Scientific (TMO) Cut to "Buy" at BidaskClubThermo Fisher Scientific (TMO) Cut to "Buy" at BidaskClub
www.americanbankingnews.com - April 14 at 8:37 PM
Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACRThermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR
www.prnewswire.com - April 14 at 5:41 PM
Thermo Scientific Krios G3i Cryo-Electron Microscope Wins Gold Edison AwardThermo Scientific Krios G3i Cryo-Electron Microscope Wins Gold Edison Award
www.prnewswire.com - April 14 at 9:31 AM
$5.63 Billion in Sales Expected for Thermo Fisher Scientific Inc. (TMO) This Quarter$5.63 Billion in Sales Expected for Thermo Fisher Scientific Inc. (TMO) This Quarter
www.americanbankingnews.com - April 13 at 4:43 AM
Lawsuit claims Thermo Fisher discriminated against ex-Marine with PTSDLawsuit claims Thermo Fisher discriminated against ex-Marine with PTSD
finance.yahoo.com - April 12 at 10:13 AM
Thermo Fisher Scientific (TMO) Receives "Buy" Rating from Morgan StanleyThermo Fisher Scientific (TMO) Receives "Buy" Rating from Morgan Stanley
www.americanbankingnews.com - April 11 at 9:20 AM
Thermo Fisher Scientific Inc. (TMO) Expected to Announce Earnings of $2.42 Per ShareThermo Fisher Scientific Inc. (TMO) Expected to Announce Earnings of $2.42 Per Share
www.americanbankingnews.com - April 11 at 3:14 AM
Thermo Fisher Scientific Announces Its First Cloud-Enabled Biological Safety CabinetThermo Fisher Scientific Announces Its First Cloud-Enabled Biological Safety Cabinet
www.prnewswire.com - April 10 at 9:42 AM
Thermo Fisher Scientific Highlights Digital Science Innovations at Analytica 2018Thermo Fisher Scientific Highlights Digital Science Innovations at Analytica 2018
finance.yahoo.com - April 10 at 9:42 AM
Thermo Fisher Scientific (TMO) & Cemtrex (CETX) Head-To-Head AnalysisThermo Fisher Scientific (TMO) & Cemtrex (CETX) Head-To-Head Analysis
www.americanbankingnews.com - April 5 at 3:21 PM
Thermo Fisher Scientific (TMO) Cut to Hold at Zacks Investment ResearchThermo Fisher Scientific (TMO) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - April 5 at 2:58 PM
Thermo Fisher Scientific (TMO) Given a $226.00 Price Target by Deutsche Bank AnalystsThermo Fisher Scientific (TMO) Given a $226.00 Price Target by Deutsche Bank Analysts
www.americanbankingnews.com - April 4 at 7:58 PM
Thermo Fisher Scientific (TMO) Upgraded by Zacks Investment Research to "Buy"Thermo Fisher Scientific (TMO) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 3 at 2:26 PM
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 25, 2018Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 25, 2018
finance.yahoo.com - April 3 at 9:37 AM
Rapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot ReleaseRapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot Release
finance.yahoo.com - April 3 at 9:37 AM
Thermo Fisher Scientific (TMO) Receives New Coverage from Analysts at Evercore ISIThermo Fisher Scientific (TMO) Receives New Coverage from Analysts at Evercore ISI
www.americanbankingnews.com - March 30 at 8:56 PM
Thermo Fisher Strong on Global Business Amid Forex WoesThermo Fisher Strong on Global Business Amid Forex Woes
finance.yahoo.com - March 28 at 4:29 PM
Zacks: Brokerages Anticipate Thermo Fisher Scientific Inc. (TMO) Will Post Quarterly Sales of $5.62 BillionZacks: Brokerages Anticipate Thermo Fisher Scientific Inc. (TMO) Will Post Quarterly Sales of $5.62 Billion
www.americanbankingnews.com - March 27 at 8:25 AM
Thermo Fisher Scientific (TMO) Stock Rating Lowered by Zacks Investment ResearchThermo Fisher Scientific (TMO) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - March 26 at 3:12 PM
Thermo Fisher Scientific Inc. (TMO) Receives Average Recommendation of "Buy" from AnalystsThermo Fisher Scientific Inc. (TMO) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 25 at 1:41 AM
Thermo Fisher Scientific Inc. (TMO) CEO Marc N. Casper Sells 40,000 SharesThermo Fisher Scientific Inc. (TMO) CEO Marc N. Casper Sells 40,000 Shares
www.americanbankingnews.com - March 23 at 4:33 PM
Wired News - Thermo Fisher Scientific Disclosed Plans to Build State-of-the-Art Pharma Services Facility in GermanyWired News - Thermo Fisher Scientific Disclosed Plans to Build State-of-the-Art Pharma Services Facility in Germany
finance.yahoo.com - March 20 at 9:23 AM
What Are Thermo Fisher Scientific’s Current Valuations?What Are Thermo Fisher Scientific’s Current Valuations?
finance.yahoo.com - March 20 at 9:23 AM
Notable ETF Inflow Detected - XLV, PFE, TMO, LLY - NasdaqNotable ETF Inflow Detected - XLV, PFE, TMO, LLY - Nasdaq
www.nasdaq.com - March 19 at 4:37 PM
Thermo Fisher Scientific Buys IntegenX, Widens HID Suite - NasdaqThermo Fisher Scientific Buys IntegenX, Widens HID Suite - Nasdaq
www.nasdaq.com - March 19 at 4:37 PM
A Look at Thermo Fisher Scientific’s Recent Research PartnershipsA Look at Thermo Fisher Scientific’s Recent Research Partnerships
finance.yahoo.com - March 19 at 10:12 AM
U.S. to cover advanced genomic testing for Medicare cancer patientsU.S. to cover advanced genomic testing for Medicare cancer patients
finance.yahoo.com - March 17 at 10:21 AM
Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human IdentificationThermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification
www.prnewswire.com - March 16 at 7:34 PM
Thermo Fisher Launches New Products in Semiconductor ManufacturingThermo Fisher Launches New Products in Semiconductor Manufacturing
finance.yahoo.com - March 16 at 10:21 AM
Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) GermanyThermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany
www.prnewswire.com - March 16 at 5:17 AM
Charité -- Universitätsmedizin Berlin tritt als jüngstes Mitglied dem Programm für Exzellenzzentren von Thermo Fisher Scientific für die Next-Generation-Sequenzierung beiCharité -- Universitätsmedizin Berlin tritt als jüngstes Mitglied dem Programm für Exzellenzzentren von Thermo Fisher Scientific für die Next-Generation-Sequenzierung bei
www.prnewswire.com - March 15 at 3:13 AM
Thermo Fisher Scientific Showcases New Solutions for Accelerating, Innovating and Enhancing Productivity in the Fab and Lab at SEMICON China 2018Thermo Fisher Scientific Showcases New Solutions for Accelerating, Innovating and Enhancing Productivity in the Fab and Lab at SEMICON China 2018
www.prnewswire.com - March 13 at 9:07 PM
Thermo Fisher Scientific Inc (TMO) Ex-Dividend Date Scheduled for March 14, 2018 - NasdaqThermo Fisher Scientific Inc (TMO) Ex-Dividend Date Scheduled for March 14, 2018 - Nasdaq
www.nasdaq.com - March 13 at 4:50 PM
$5.62 Billion in Sales Expected for Thermo Fisher Scientific Inc. (TMO) This Quarter$5.62 Billion in Sales Expected for Thermo Fisher Scientific Inc. (TMO) This Quarter
www.americanbankingnews.com - March 9 at 3:30 AM
Insider Selling: Thermo Fisher Scientific Inc. (TMO) CFO Sells 2,500 Shares of StockInsider Selling: Thermo Fisher Scientific Inc. (TMO) CFO Sells 2,500 Shares of Stock
www.americanbankingnews.com - March 6 at 6:34 PM
Comparing Thermo Fisher Scientific (TMO) and Quidel (QDEL)Comparing Thermo Fisher Scientific (TMO) and Quidel (QDEL)
www.americanbankingnews.com - March 6 at 3:21 PM
Thermo Fisher Scientific Inc. (TMO) Stake Decreased by ETRADE Capital Management LLCThermo Fisher Scientific Inc. (TMO) Stake Decreased by ETRADE Capital Management LLC
www.americanbankingnews.com - March 6 at 1:34 PM
Tocqueville Asset Management L.P. Cuts Holdings in Thermo Fisher Scientific Inc. (TMO)Tocqueville Asset Management L.P. Cuts Holdings in Thermo Fisher Scientific Inc. (TMO)
www.americanbankingnews.com - March 6 at 11:12 AM
Granite Investment Advisors LLC Buys Shares of 11,063 Thermo Fisher Scientific Inc. (TMO)Granite Investment Advisors LLC Buys Shares of 11,063 Thermo Fisher Scientific Inc. (TMO)
www.americanbankingnews.com - March 6 at 7:55 AM
Chilton Capital Management LLC Cuts Stake in Thermo Fisher Scientific Inc. (TMO)Chilton Capital Management LLC Cuts Stake in Thermo Fisher Scientific Inc. (TMO)
www.americanbankingnews.com - March 6 at 5:30 AM
A Look at Stryker’s Recent Dividend AnnouncementA Look at Stryker’s Recent Dividend Announcement
finance.yahoo.com - March 5 at 4:41 PM
Thermo Fisher Scientific Inc. (TMO) Position Lifted by Green Valley Investors LLCThermo Fisher Scientific Inc. (TMO) Position Lifted by Green Valley Investors LLC
www.americanbankingnews.com - March 5 at 4:07 PM
Thermo Fisher Scientific Inc. (TMO) Stake Lowered by Matrix Asset Advisors Inc. NYThermo Fisher Scientific Inc. (TMO) Stake Lowered by Matrix Asset Advisors Inc. NY
www.americanbankingnews.com - March 5 at 3:30 PM
Thermo Fisher Scientific Inc. (TMO) Position Lifted by Kings Point Capital ManagementThermo Fisher Scientific Inc. (TMO) Position Lifted by Kings Point Capital Management
www.americanbankingnews.com - March 5 at 2:57 PM

SEC Filings

Thermo Fisher Scientific (NYSE:TMO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Thermo Fisher Scientific (NYSE:TMO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Thermo Fisher Scientific (NYSE TMO) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.